United States
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
13.39
|
Sept. 30, 2024 | USD 1.05 | 3.96% |
|
United States |
|
2 |
4.96
|
Sept. 30, 2024 | USD 99.01 | 4.67% |
|
United States |
|
3 |
2.97
|
Sept. 30, 2024 | USD 62.54 | -2.36% |
|
United States |
|
4 |
2.53
|
Sept. 30, 2024 | USD 70.19 | 2.45% |
|
United States |
|
5 |
2.47
|
Sept. 28, 2024 | USD 8.87 | -3.17% |
|
United States |
|
6 |
2.23
|
Sept. 30, 2024 | USD 0.81 | 0.53% |
|
United States |
|
7 |
2.13
|
Sept. 30, 2024 | USD 1.43 | -4.03% |
|
United States |
|
8 |
2.12
|
Sept. 30, 2024 | USD 111.11 | 1.26% |
|
United States |
|
9 |
2.04
|
Sept. 30, 2024 | USD 7.66 | -1.42% |
|
United States |
|
10 |
1.97
|
Sept. 30, 2024 | USD 65.65 | -1.41% |
|
United States |
|
11 |
1.80
|
Sept. 30, 2024 | USD 35.79 | -1.16% |
|
United States |
|
12 |
1.60
|
Sept. 30, 2024 | USD 4.22 | NA |
|
United States |
|
13 |
1.55
|
Sept. 30, 2024 | USD 267.04 | -0.35% |
|
United States |
|
14 |
1.53
|
Sept. 30, 2024 | USD 10.37 | 0.39% |
|
United States |
|
15 |
1.30
|
Sept. 30, 2024 | USD 84.13 | -1.40% |
|
United States |
|
16 |
1.19
|
Sept. 30, 2024 | USD 79.17 | -0.84% |
|
United States |
|
17 |
1.16
|
Sept. 30, 2024 | USD 61.26 | -2.69% |
|
United States |
|
18 |
1.14
|
Sept. 28, 2024 | USD 79.96 | 0.69% |
|
United States |
|
19 |
1.11
|
Sept. 30, 2024 | USD 67.79 | -2.46% |
|
United States |
|
20 |
0.97
|
Sept. 30, 2024 | USD 131.05 | -0.04% |
|
United States |
|
21 |
0.97
|
Sept. 30, 2024 | USD 1.79 | -0.56% |
|
United States |
|
22 |
0.96
|
Sept. 30, 2024 | USD 13.47 | -1.25% |
|
United States |
|
23 |
0.89
|
Sept. 30, 2024 | USD 3.05 | -0.33% |
|
United States |
|
24 |
0.83
|
Sept. 30, 2024 | USD 3.70 | -8.19% |
|
United States |
|
25 |
0.83
|
Sept. 27, 2024 | USD 13.52 | 1.05% |
|
United States |
|
26 |
0.81
|
Sept. 30, 2024 | USD 161.08 | 1.85% |
|
United States |
|
27 |
0.80
|
Sept. 30, 2024 | USD 3.05 | -0.33% |
|
United States |
|
28 |
0.78
|
Sept. 30, 2024 | USD 21.93 | -1.62% |
|
United States |
|
29 |
0.75
|
Sept. 27, 2024 | USD 138.83 | 2.72% |
|
United States |
|
30 |
0.75
|
Sept. 28, 2024 | USD 556.99 | 0.27% |
|
United States |
|
31 |
0.73
|
Sept. 29, 2024 | USD 41.10 | -7.87% |
|
United States |
|
32 |
0.72
|
Sept. 27, 2024 | USD 148.22 | 1.40% |
|
United States |
|
33 |
0.72
|
Sept. 30, 2024 | USD 18.24 | -0.06% |
|
United States |
|
34 |
0.72
|
Oct. 31, 2024 | USD 3.26 | 1.24% |
|
United States |
|
35 |
0.68
|
Sept. 30, 2024 | USD 99.89 | 4.44% |
|
United States |
|
36 |
0.67
|
Sept. 30, 2024 | USD 362.80 | 0.50% |
|
United States |
|
37 |
0.66
|
Sept. 28, 2024 | USD 166.09 | 0.31% |
|
United States |
|
38 |
0.61
|
Sept. 30, 2024 | USD 92.62 | -2.15% |
|
United States |
|
39 |
0.58
|
Sept. 30, 2024 | USD 8.01 | -4.19% |
|
United States |
|
40 |
0.55
|
Sept. 30, 2024 | USD 235.80 | -0.17% |
|
United States |
|
41 |
0.54
|
Sept. 30, 2024 | USD 16.15 | 7.38% |
|
United States |
|
42 |
0.53
|
Sept. 30, 2024 | USD 95.65 | 1.10% |
|
United States |
|
43 |
0.52
|
Sept. 28, 2024 | USD 70.20 | -0.13% |
|
United States |
|
44 |
0.48
|
Sept. 30, 2024 | USD 16.29 | 2.65% |
|
United States |
|
45 |
0.48
|
Sept. 30, 2024 | USD 104.71 | -0.74% |
|
United States |
|
46 |
0.46
|
Sept. 30, 2024 | USD 10.15 | 0.50% |
|
United States |
|
47 |
0.46
|
Sept. 30, 2024 | USD 6.84 | -2.98% |
|
United States |
|
48 |
0.44
|
Sept. 30, 2024 | USD 45.00 | -3.72% |
|
United States |
|
49 |
0.42
|
Sept. 29, 2024 | USD 179.17 | 0.35% |
|
United States |
|
50 |
0.39
|
Sept. 30, 2024 | USD 14.70 | -4.54% |
|
United States |
The Medical Instruments company in United States with the highest Debt to Equity Ratio is Nuwellis, Inc. (NasdaqCM: NUWE) at 13.39.
The Medical Instruments company in United States with the lowest Debt to Equity Ratio is Mettler-Toledo International Inc. (NYSE: MTD) at -13.48.
The top 10 Medical Instruments companies in United States by Debt to Equity Ratio are Nuwellis, Inc., iRhythm Technologies, Inc., TransMedics Group, Inc., Solventum Corporation, Bioventus Inc., Outset Medical, Inc., Apyx Medical Corporation, MKS Instruments, Inc., Zynex, Inc. and RadNet, Inc..
The bottom 10 Medical Instruments companies in United States by Debt to Equity Ratio are Mettler-Toledo International Inc., Embecta Corp., OneMedNet Corporation, Envoy Medical, Inc., Elutia Inc., NeurAxis, Inc., BioSig Technologies, Inc., Semler Scientific, Inc., Intuitive Surgical, Inc. and Utah Medical Products, Inc..